We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Two UK-based companies have been tasked with developing lateral flow immunoassay tests – antibody tests – for use as rapid diagnostic tools for the novel coronavirus disease, COVID-19.
